Cargando…
Enrofloxacin and Toltrazuril Are Able to Reduce Toxoplasma gondii Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy
Classical treatment for congenital toxoplasmosis is based on combination of sulfadiazine and pyrimethamine plus folinic acid. Due to teratogenic effects and bone marrow suppression caused by pyrimethamine, the establishment of new therapeutic strategies is indispensable to minimize the side effects...
Autores principales: | da Silva, Rafaela J., Gomes, Angelica O., Franco, Priscila S., Pereira, Ariane S., Milian, Iliana C. B., Ribeiro, Mayara, Fiorenzani, Paolo, dos Santos, Maria C., Mineo, José R., da Silva, Neide M., Ferro, Eloisa A. V., de Freitas Barbosa, Bellisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526852/ https://www.ncbi.nlm.nih.gov/pubmed/28798905 http://dx.doi.org/10.3389/fcimb.2017.00340 |
Ejemplares similares
-
Biogenic Silver Nanoparticles Can Control Toxoplasma gondii Infection in Both Human Trophoblast Cells and Villous Explants
por: Costa, Idessania Nazareth, et al.
Publicado: (2021) -
Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants
por: de Souza, Guilherme, et al.
Publicado: (2021) -
Rottlerin-mediated inhibition of Toxoplasma gondii growth in BeWo trophoblast-like cells
por: Ietta, Francesca, et al.
Publicado: (2017) -
Heme Oxygenase-1 Induction in Human BeWo Trophoblast Cells Decreases Toxoplasma gondii Proliferation in Association With the Upregulation of p38 MAPK Phosphorylation and IL-6 Production
por: Almeida, Marcos Paulo Oliveira, et al.
Publicado: (2021) -
Azithromycin is able to control Toxoplasma gondii infection in human villous explants
por: Castro-Filice, Letícia S, et al.
Publicado: (2014)